Profile of:

Nurullah Akkoc

I graduated from the Medical Faculty of Ege University in Izmir, Turkey in 1982. I obtained postgraduate training in the USA and Germany. I served as the Chief of the Division of Rheumatology and Immunology between 1998 and 2017 at Dokuz Eylul University in Izmir. Currently I am working as the chief of the Division of Rheumatology at the Department of Medicine of the Celal Bayar University in Manisa, a town near Izmir. I served as the President of Turkish Society for Rheumatology (2012-2014), and as the Vice President (2014-2015) and the President of Turkish Rheumatology Federation (2015-2016). My primary research interest is clinical and genetic aspects of ankylosing spondylitis and related spondyloarthritis, rheumatoid arthritis, and Takayasu’s arteritis. I have also published more than 300 scientific articles, letters, and abstracts. I have been a member of the Assessment in Ankylosing Spondylitis International Society (ASAS) since 1996. I am also a member of the scientific committee of the The EuroSpA Collaboration Network. I serve as a co-section editor for SpA Current Rheumatology Reports.

Full name: Nurullah Akkoc

Current country: Turkey

Membership level: Full

Type of membership: Member

Number of publications: 21

Does obesity affect treatment response to secukinumab and its survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry (2023)

Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons (2023)

Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration (2022)

A real-life analysis of patients with rheumatologic diseases on biological treatments: Data from TURKBIO Registry (2022)

The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis (2022)

European bio-naive spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response (2022)

Polygenic Risk Scores have high diagnostic capacity in ankylosing spondylitis. (2021)

European bio-naïve spondyloarthritis patients initiating TNFi: Time trends in baseline characteristics, treatment retention and response (2021)

Do mobility exercises in different environments have different effects in ankylosing spondylitis? (2021)

JAK Inhibitors for Axial Spondyloarthritis: What does the Future Hold? (2021)

Assessing rheumatologists’ attitudes and utilization of classification criteria for ankylosing spondylitis and axial spondyloarthritis: a global effort (2021)

Is Axial Spondyloarthritis More Common Than Rheumatoid Arthritis? (2020)

The adaptation of the Turkish version of the Assessment of Knowledge in Ankylosing Spondylitis Patients by a Self-Administered Questionnaire (2020)

Prevalence of Spondyloarthritis Among Patients Who Underwent Lumbar Disc Herniation Surgery (2020)

Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis. (2020)

Genome-wide association study in Turkish and Iranian populations identify rare familial Mediterranean fever gene (MEFV) polymorphisms associated with ankylosing spondylitis (2019)

Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis (2018)

Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative (2018)

An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS (2018)

Do major histocompatibility complex tag single nucleotide polymorphisms accurately identify HLA-B27 in the Turkish population? (2017)

Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies (2017)